Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma-Reference-Cited by-同舟云学术

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

Published:2019-01-04 Issue:2 Volume:11 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Chua Vivian¹^ORCID,Orloff Marlana²,Teh Jessica LF¹,Sugase Takahito²,Liao Connie¹,Purwin Timothy J¹,Lam Bao Q²,Terai Mizue²,Ambrosini Grazia³,Carvajal Richard D³⁴,Schwartz Gary³⁴,Sato Takami²,Aplin Andrew E¹⁵^ORCID

Affiliation:

1. Department of Cancer Biology Thomas Jefferson University Philadelphia PA USA

2. Department of Medical Oncology Thomas Jefferson University Philadelphia PA USA

3. The Herbert Irving Comprehensive Cancer Center Columbia University Medical Center New York NY USA

4. Division of Hematology/Oncology Columbia University Medical Center New York NY USA

5. Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia PA USA

Funder

American Association for Cancer Research

National Cancer Center

Dr. Ralph and Marian Falk Medical Research Trust

Melanoma Research Alliance

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201809081

Reference47 articles.

1. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma

2. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells

3. Angiogenin Secretion From Hepatoma Cells Activates Hepatic Stellate Cells To Amplify A Self-Sustained Cycle Promoting Liver Cancer

4. Transcriptional Addiction in Cancer

5. NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress;Science Signaling;2024-06-11

2. RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma;Scientific Reports;2024-04-23

3. The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling;Experimental Hematology & Oncology;2024-03-04

4. Uveal melanoma modeling in mice and zebrafish;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

5. RAPID RESISTANCE TO BET INHIBITORS IS MEDIATED BY FGFR1 IN GLIOBLASTOMA;2023-12-20